Midwest Professional Planners LTD. Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Midwest Professional Planners LTD. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 210.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 925 shares of the medical equipment provider’s stock after purchasing an additional 627 shares during the quarter. Midwest Professional Planners LTD.’s holdings in Intuitive Surgical were worth $332,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ISRG. Ativo Capital Management LLC grew its holdings in Intuitive Surgical by 2.2% during the 3rd quarter. Ativo Capital Management LLC now owns 1,327 shares of the medical equipment provider’s stock valued at $1,319,000 after buying an additional 29 shares in the last quarter. Bell Investment Advisors Inc purchased a new position in Intuitive Surgical during the 3rd quarter valued at approximately $29,000. Eagle Bay Advisors LLC grew its holdings in Intuitive Surgical by 48.5% during the 3rd quarter. Eagle Bay Advisors LLC now owns 101 shares of the medical equipment provider’s stock valued at $101,000 after buying an additional 33 shares in the last quarter. Bluestein R H & Co. grew its holdings in Intuitive Surgical by 3.3% during the 3rd quarter. Bluestein R H & Co. now owns 1,087 shares of the medical equipment provider’s stock valued at $1,081,000 after buying an additional 35 shares in the last quarter. Finally, Parcion Private Wealth LLC grew its holdings in Intuitive Surgical by 3.4% during the 4th quarter. Parcion Private Wealth LLC now owns 1,109 shares of the medical equipment provider’s stock valued at $344,000 after buying an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 83.69% of the company’s stock.

In other news, EVP Myriam Curet sold 2,478 shares of Intuitive Surgical stock in a transaction on Wednesday, February 16th. The stock was sold at an average price of $289.00, for a total value of $716,142.00. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.90% of the company’s stock.

ISRG traded up $12.00 during trading on Friday, hitting $223.69. 2,250,282 shares of the stock were exchanged, compared to its average volume of 2,675,108. The firm has a 50 day simple moving average of $269.05 and a 200 day simple moving average of $303.94. The firm has a market cap of $80.30 billion, a price-to-earnings ratio of 49.75, a P/E/G ratio of 4.81 and a beta of 1.26. Intuitive Surgical, Inc. has a 1 year low of $206.60 and a 1 year high of $369.69.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its quarterly earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.07. Intuitive Surgical had a return on equity of 14.16% and a net margin of 27.84%. The business had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business posted $1.17 EPS. The business’s revenue was up 15.1% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 4.14 EPS for the current year.

Several equities analysts have weighed in on ISRG shares. Raymond James cut their price target on Intuitive Surgical from $334.00 to $330.00 and set an “outperform” rating for the company in a report on Friday, April 22nd. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $257.00 price objective for the company. in a research note on Wednesday, April 27th. Redburn Partners lowered Intuitive Surgical from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 25th. Stifel Nicolaus lowered their price objective on Intuitive Surgical from $370.00 to $325.00 and set a “buy” rating for the company in a research note on Friday, January 21st. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $310.00 to $316.00 and gave the company an “overweight” rating in a research note on Friday, April 22nd. Eight equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $326.60.

About Intuitive Surgical (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.